Clinical Trials Browser

Phase 1 × Colorectal Neoplasms × Sorafenib × Clear all

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Mesothelioma, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Phase 1 Completed

180 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT00780169 2013-05-13

Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer

Phase 1 Completed

16 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00779311 2011-11-02

A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer

Phase 1 Terminated

8 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer

A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer